Skip to main content
. 2015 Jan;12(1):46–56. doi: 10.1513/AnnalsATS.201409-415OC

Table 1.

Patient demographics and clinical characteristics of patients categorized as low or high ketone before administration of l-carnitine or placebo

Variable Low Ketones (n = 15) High Ketones (n = 15) P Value
Age, yr (IQR) 60 (52, 68) 69 (60, 74) 0.096
Race, n (%)      
 White 11 (73.33) 13 (86.67) 0.410
 African American 4 (26.67) 2 (13)  
Male, n (%) 12 (80) 9 (60) 0.268
Comorbidities, n (%)      
 Coronary artery disease 5 (33) 2 (13) 0.235
 Congestive heart failure 2 (13) 4 (27) 0.410
 COPD 4 (27) 4 (27) 0.999
 DNR 0 (0) 0 (0) 0.999
 Hypertension 10 (67) 11 (73) 0.714
 Diabetes 4 (27) 6 (40) 0.473
 Chronic renal insufficiency 2 (13) 4 (27) 0.410
Baseline laboratory values (IQR)      
 Platelets, cells/mm3 159 (82, 232) 196 (158, 335) 0.280
 Creatinine, mg/dl 1.8 (1.4, 2.4) 1.7 (1.5, 2.7) 0.945
 Total bilirubin, mg/dl 2.1 (0.6, 3.1) 1.2 (0.9, 1.9) 1.000
 Lactate, mmol/L 2.9 (2.2, 5.1) 1.9 (1.6, 4.0) 0.085
SOFA, score (IQR) 10 (9, 14) 12.5 (8, 14) 0.871

Definition of abbreviations: COPD = chronic obstructive pulmonary disease; DNR = Do Not Resuscitate order; SOFA = Sequential Organ Failure Assessment.

Note: Data represent medians and interquartile ranges (IQRs) or absolute numbers with percentages (%), as appropriate.